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Expression of Hox genes is tightly regulated in spatial and temporal domains. Evx2 is located next to Hoxd13 within 8 kb on
the opposite DNA strand. Early in development, the pattern of Hoxd13 expression resembles that of Evx2 in limb and genital
buds. After 10 dpc, however, Evx2 begins to be expressed in CNS as well. We analyzed the region responsible for these
differences using ES cell techniques, and found that the intergenic region between Evx2 and Hoxd13 behaves as a boundary
element that functions differentially in space and time, specifically in the development of limbs, genital bud, and brain. This
boundary element comprises a large sequence spanning several kilobases that can be divided into at least two units:
a constitutive boundary element, which blocks transcription regulatory influences from the chromosomal environment, and
a regulatory element, which controls the function of the constitutive boundary element in time and space.
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Promoter. PLoS ONE 2(1): e175. doi:10.1371/journal.pone.0000175
INTRODUCTION
Protein-DNA interactions on DNA cis-regulatory elements and
cross-talk between these complexes underlie precise transcription
regulation. Since genes are embedded in huge DNA molecules
containing abundant putative cis-regulatory elements such as
enhancer and promoter sequences, the interactions of cis-
regulatory sequences is extremely complicated. To achieve proper
transcription regulation, selection of these interactions is in-
evitable. Some DNA regions are believed to play roles controlling
traffic interactions among cis-regulatory elements.
Boundary elements divide a chromosome into independent
units for transcription regulation. Mainly through genetic studies
of Drosophila melanogaster, several candidate boundary elements (also
known as insulator sequences or insulators) have been isolated [1–
5]. Many of these elements act as components for homeotic gene
regulation [1,2,4,6,7]. Enhancer activity must be well organized to
achieve the proper transcription regulation of clustered homeotic
genes needed for the development of proper anteroposterior
segmental identity within an organism’s body. Mutations within
such boundary elements alter gene expression profiles by leading
misuse of these enhancer sequences and cause morphological shifts
in segmental identities [2,8].
A similar phenomenon has been observed in mammalian
orthologous homeotic complex genes [9,10]. Hox genes are
responsible for the anterior-posterior identity of the mammalian
body, as is in the case of Drosophila. Misregulation of Hox genes
causes morphological alterations [11–13] and can even be
detrimental [14,15]. As with Drosophila, enhancer-promoter inter-
actions in mammals also require precise organization for Hox gene
expression regulation [9,10]. An enhancer that drives Hoxd11 in
the cecum cannot associate with the promoter of Hoxd13, which
is about 10 kb away from Hoxd11 [9,10]. Intergenic deletion of
Hoxd12-Hoxd13, however, causes Hoxd13 to be expressed in the
cecum in an expression pattern resembling that of Hoxd11 [9,10].
Taken together, these results indicate that the Hoxd12-Hoxd13
intergenic sequence functions as an insulator which prevents
enhancer access to promoter.
Here, we report another candidate insulator sequence in the
HoxD complex—the Evx2-Hoxd13 intergenic region. We demon-
strated that this fragment possesses position-effect protection as
well as insulator activity, two activities that are required for
a sequence to be considered as a boundary sequence. Further-
more, we found that this boundary sequence functions in a tissue-
specific manner, and that the regulation of tissue specificity can be
separated from the boundary activity.
RESULTS
Differential expression profile of Evx2 and Hoxd13
Hoxd13 is located within 8 kb of the Evx2 gene, which is encoded
on the opposite strand of DNA from other HoxD genes (Figure 1A).
Examination of 11 days post-coitus (dpc) embryos revealed that
the expression profile of Evx2 is distinct from that of its neighbor,
Hoxd13 (Figure 1B) [16]. In younger embryos, however, the
expression profiles of Evx2 and Hoxd13 are almost identical.
Expression of Evx2 in central nervous system (CNS) begins at 10
dpc, being especially prominent in the isthmus (Figure 1B). Hoxd13,
however, is never expressed in anterior structures throughout
embryonic and fetal development (Figure 1B). We previously
created mice harboring a series of Hoxd9/lacZ marker transgene
insertions into the region surrounding Evx2 (Figure S1A) [14].
When the transgene was positioned immediately downstream of
the Evx2 poly(A)
+ signal (relI), lacZ expression mirrored Evx2
expression; however, when the transgene was positioned half-way
between the Evx2 and Hoxd13 initiation codons (relO), lacZ
expression resembled Hoxd13 (i.e., lacked CNS expression in 11
dpc embryos) (Figure S1B) [14]. Enhancer activities driving the
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located about 250 kb downstream from Evx2 [17]. Taken together,
these results suggest that an enhancer blocker element (insulator)
exists in the vicinity of the Evx2 promoter, and that this insulator
prevents enhancer(s) from interacting with Hoxd13 in the CNS
(Figure 1C) [14,18].
Molecular dissection of Evx2-Hoxd13 insulator
activity
Using homologous recombination in ES cells, we translocated
candidate boundary sequences to the region immediately down-
stream of Evx2 along with the Hoxd9/lacZ reporter transgene
(Figure 1A; Figure 2A, B). The resulting ES cells were injected into
blastocysts to create transgenic mouse embryos. Chimeras and
progeny from the chimeras were then stained for b-galactosidase
activity. If the candidate boundary sequence has insulator activity,
then lacZ expression pattern should resemble that of Hoxd13;
otherwise, lacZ expression pattern should resemble that of Evx2
(i.e., in the CNS).
From our previous observations [14], we predicted that the
boundary sequence is located between the Evx2 promoter and the
NsiI site, half-way between Evx2 and Hoxd13 (i.e., the relO
transgene insertion site) [14] (Figure S1). Indeed, when the entire
candidate sequence and reporter transgene were inserted into the
relO transgene insertion site (i.e., the 5 kb fragment between XhoI
site in exon1 of Evx2 and NsiI site), lacZ-staining pattern in
embryos was similar to that of Hoxd13, indicating that the XhoI-
NsiI (XNs) fragment blocked enhancer activity in CNS (Figure 2C).
This observation guided our experimental design.
To assess the insulator activity in more detail, we divided the
XNs fragment into three overlapping segments of about 2 kb
each—XhoI-BamHI (XB), EcoRI-BglII (EBg), and BamHI-BamHI
(BB)—starting from the region adjacent to the Evx2 initiation
codon (Figure 2B). We then prepared transgenic mice harboring
each fragment along with the Hoxd9/lacZ reporter transgene.
Transgenic animals harboring either EBg or BB displayed an
Evx2-like expression pattern (Figure 2D, E), indicating that these
two fragments failed to block interaction between the CNS
enhancer and the Hoxd9/lacZ promoter (Figure 2). On the other
hand, transgenic animals harboring XB displayed no transgene
Figure 1. Genomic structure and expression patterns of Evx2-Hoxd13.
(A) Evx2 and Hoxd13 genes are located within 8 kb of each other. (B)
Expression patterns of Evx2 (left panel) and Hoxd13 (right panel) in 11
dpc embryos. Evx2 is expressed in the CNS, as well as in the limbs and
genital buds, regions that also express Hoxd13. (c) Scheme illustrating
the hypothesis that Evx2 and Hoxd13 display segregated expression
patterns. Enhancers located 39 from Evx2 have differential access to the
Evx2 promoter and the Hoxd13 promoter. The intergenic region of
Evx2-Hoxd13 prevents enhancer access in CNS but not in limbs.
doi:10.1371/journal.pone.0000175.g001
Figure 2. Analysis of the insulator fragment using targeted transgene
experiments. (A) Scheme of experimental design. The Hoxd9/lacZ
transgene, along with an insulator candidate fragment, was inserted
into the region just downstream of Evx2 by a gene-targeting technique
using ES cells. The resulting ES cells were injected into blastocysts to
establish transgenic mice. (B) The XhoI-NsiI (XNs) fragment (red) was
separated into three fragments—BamHI-BamHI (BB), EcoRI-BglII (EBg),
and XhoI-BamHI (XB)—each of which were translocated together with
the Hoxd9/lacZ reporter transgene. (C–H) LacZ-stained 11 dpc embryos.
XNs (C) and XB (F) blocked lacZ gene expression in brain, while BB (D)
and EBg (E) failed to do so. Based on these results, we divided the XB
fragment into two fragments—XhoI-EcoRI (XE) and EcoRI-EcoRI (EE)—
which we used to make targeted transgenic mice having a similar
configuration to that shown in panel (A). Embryos harboring XE (G) and
EE (H) displayed lacZ gene expression in brain but did not display
expression patterns indicative of insulation activity.
doi:10.1371/journal.pone.0000175.g002
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activity (Figure 2F; Figure S2).
To assess the insulator activity of the XB fragment further, we
divided the 2.5 kb fragment into three pieces (Figure 2B) and
found that none of these shorter fragments showed insulator
activity by blocking enhancer interactions with the reporter
transgene (Figure 2G, H). This indicates that a particular length
of DNA containing multiple protein binding sites dispersed within
the 2.5 kb XB fragment is required for proper insulator function
and that insulator activity is a consequence of complex DNA-
protein interactions (Figure 2). Bell and colleagues reported that
the binding sequence of the transcription factor CTCF is necessary
and sufficient for enhancer insulation activity of HS4 of the
chicken b-globin locus [19]. However, unlike in the case of the b-
globin insulator, we were unable to isolate a small DNA element
that functioned as an enhancer blocker in our study system. In
addition, an in silico search using TESS (http://www.cbil.upenn.
edu/tess/) failed to identify any candidate association sites for
CTCF.
Neighboring sequence regulates Evx2-Hoxd13
insulator activity
Comparison of the lacZ expression patterns of XNs- and XB-
targeted transgenic mice revealed distinct differences (Figure 3A,
B). As shown in Figure 2, both fragments blocked the expression of
the lacZ reporter gene in the CNS. In XNs mice, we observed lacZ
expression in the limbs and genital bud (i.e., resembling Hoxd13
expression), whereas in XB mice, lacZ expression was absent in the
limbs and genital bud (Figure 3B). These results suggest that (1) the
XB fragment is a constitutive insulator, and (2) the specificity of
the blocker activity is determined by a sequence in the BamHI-NsiI
site (BNs) outside of the core blocker sequence, XhoI-BamHI
(Figure S3). The sequence in the BNs fragment may counteract or
cancel the blocking activity of the XB fragment in limbs and
genital bud, therefore, posterior HoxD genes are expressed in the
limbs and genital bud (Figure 3C). Thus, the blocking sequence in
the Evx2-Hoxd13 system can be divided into two units—
a constitutive blocker and a blocker regulator.
Methylation status of Evx2-Hoxd13 insulator
sequence
To gain insight into the molecular mechanisms of the insulator
activity of the XB fragment, we next analyzed chromatin
structures for the methylation status of DNA residues, a key
means of regulating gene transcription. Indeed, methylation is
thought to contribute to gene silencing, as evidenced by the high
frequency of methylated residues often observed in DNA
surrounding silenced promoters [20]. It is probable that the
methylation status of residues within functional insulator differs
among organs or differs depending on a gene’s transcription status,
as observed in the case of the H19 imprinting system [21,22]. In
our system, since insulation takes place only in hindbrain and not
in limbs, we examined and compared the methylation status of
DNA samples from the hindbrain and forelimb of 11 dpc embryos.
The samples spanned over 1,700 bp of DNA fragment within the
insulator fragment, as assessed by the bisulfite method [23].
Hindbrain DNA samples contained methylated cytosine
residues at relatively low to moderate frequencies (Figure 4). By
contrast, forelimb DNA samples contained essentially no methyl-
ated residues (Figure 4), which is consistent with the absence of
insulator activity in limbs.
Lethality of targeted transgenic mice and Hoxd13
expression
To further investigate the enhancer blocking activity of the XB
fragment, we examined the expression patterns of Hoxd13 and
Evx2 in targeted transgenic mice harboring the XB fragment. Our
examination of several litters of 11.5 dpc embryos identified no
homozygotic (XB/XB) targeted transgenic mice. With further
analysis, we could not find the homozygous allele, even among 7.5
dpc embryos (Table 1). We did find, however, the BB/BB allele
among 8.5 and 11.5 dpc embryos from one of the control lines
harboring the BB targeted transgene (Table 1). Since lethality
could not be segregated after more than 5 generations of out-
breeding, we concluded that the lethal phenotype is closely linked
to the presence of an additional copy of the XB fragment next to
the Evx2 gene.
To investigate the possible misregulation of Hoxd13 or Evx2
transcription resulting from insertion of the XB-containing
Figure 3. Insulation activity is spatially dependent. (A) Design of two
targeted transgenic mice. XNs and XB as in Figure 2A. (B) Expression
pattern of XNs- and XB-transgenic mouse embryos. XNs 11 dpc
embryos expressed lacZ in the limbs and genital bud, whereas XB
embryos did not. Limbs are shown in the boxed areas and genital buds
are shown in the middle panels. (C) Scheme illustrating the regulation
underlying enhancer-promoter interaction. Within the CNS, the XB
fragment prevents interaction between the enhancer and Hoxd13
promoter, while the BB fragment blocks the insulator activity of the XB
fragment within the limbs and genital bud.
doi:10.1371/journal.pone.0000175.g003
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embryos from the XB transgenic line by real-time PCR
(Figure 5A). Three separate samples of cDNA prepared from
three litters of internally bred wild-type mouse embryos and six
samples of cDNA from six litters of internally bred BB mouse
embryos were used as controls. We compared expression data
from these controls to the Hoxd13 expression measured from eight
cDNA samples prepared from 8 litters of embryos resulting from
the breeding of XB heterozygote mice. While litters resulting from
the breeding of wild-type and BB mice did not express Hoxd13,
litters resulting from the breeding of XB mice expressed Hoxd13,
although expression levels varied among the XB litters (Figure 5A).
These results suggest that mice of the XB transgenic line expressed
Hoxd13 prematurely, before the 7-dpc stage, and the lethality
observed in these mice was due to this premature expression.
Previously, we proposed that a repressive region outside of the
HoxD complex is responsible for the early repression of genes in
the HoxD complex, preventing the premature expression of Hoxd
genes before the 7-dpc stage [14]. The presence of an extra copy of
the XB fragment, which acts as a constitutive boundary element
when the regulatory sequence (BB fragment) is absent and when it
is inserted between the repressive region and HoxD complex, may
interfere with the repression from the repressive region thereby
causing Hoxd genes—in this case Evx2 and Hoxd13 genes—to be
expressed prematurely (Figure 5B). Taken together, these findings
suggest that the XB fragment possesses protection activity against
repression as well as enhancer blocker activity.
XB protects against repression from chromosomal
environment
Exogenous genes introduced into a genome often become
repressed over time by the chromosomal environment surround-
ing their insertion sites. Our observations indicated that insertion
of the extra copy of XB fragment protects the neighboring pro-
moters, Evx2 or Hoxd13 in this case, against repression (Figure 5),
we examined whether this protection is also operative when the
XB fragment is positioned randomly in the genome.
We made two constructs—one containing the fluorescent
protein Venus (Construct I), and the other containing the Venus
marker gene bounded on both sides by the XB fragment
(Construct II) (Figure 6A; for XB, see Figure 2, 3). Both of these
constructs also harbored a neomycin-resistance marker to facilitate
isolation of stable transformants. These constructs were introduced
into NIH3T3 cells, which were then cultured in G418-containing
media for one week to select neomycin-resistant colonies of
randomly integrated transformed cell lines (Figure 6B).
Twelve stably transformed colonies containing each construct
were selected. Most of the clones contained few copies of the
transgene (1–5 copies), as estimated by genomic Southern hybridi-
zation. After isolation, colonies were maintained in media lacking
neomycin and maintenance of Venus fluorescence was assessed
by fluorescence-activated cell sorting (FACS) (Figure 6B). After
1 month of culturing in media lacking neomycin, most clones
continued to express the Venus marker, except for one clone
harboring Construct II in which the transgene may have become
disrupted at the beginning of the experiment (Figure 6C). After
6 months of culturing, Venus expressed by clones harboring
Construct I were dramatically different from that by clones
harboring Construct II (Figure 6C). Seven of 12 Construct I clones
lost fluorescence almost completely, while only three of 12 Con-
Figure 4. Methylation profile of insulator fragment. (A) Hindbrain and
forelimbs were dissected from 11 dpc embryos to obtain the DNA used
for the methylation assays. (B) Map of the tested fragment. Red line
represents the insulator (XB fragment) and blue line represents the
regulator (BB fragment). Bisulfite-treated genomic DNA was subjected
to PCR using three sets of primers (indicated by arrows; see
Experimental Procedures). Primer pairs for one PCR reaction have
matching arrow color. (C) Ten clones from each PCR product were
sequenced. Their methylation status is shown here. White circles
represent methylated cytosine residues, while black circles represent
non-methylated cytosine residues.
doi:10.1371/journal.pone.0000175.g004
Table 1. Segregation of genotype in internally bred, targeted
transgenic mice
......................................................................
Genotype
stage (dpc) Wild type (2/2) XB/2 XB/XB
7.5 (n=40) 8 (20%) 32 (80%) 0
8.5 (n=32) 13 (40.6%) 19 (50.9%) 0
11.5 (n=46) 12 (26.1%) 34 (73.9%) 0
Genotype
stage (dpc)
Wild type (2/2) BB/2 BB/BB
8.5 (n=32) 7 (21.9%) 12 (37.5%) 13 (40.6%)
11.5 (n=37) 8 (21.6%) 26 (70.3%) 3 (8.11%)
doi:10.1371/journal.pone.0000175.t001
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of 12 Construct I clones lost fluorescence, whereas seven of 12
Construct II clones retained fluorescence nearly completely
(.75% of cells retained fluorescence). Overall, the XB-flanked
Venus marker apparently maintained fluorescence more efficiently
than the unflanked Venus marker (Figure 6C). These results
strongly suggest that the XB fragment conveys protection regard-
less of its position in the genome.
DISCUSSION
Mammalian Hox genes form a tightly packed gene cluster within
the genome [24]. Their genomic structure is believed to be highly
correlated to the transcription mechanisms underlying their
collinear expression [25]. Recent studies have suggested that the
initiation of Hox expression requires the DNA domains outside of
the gene cluster, domains that regulate the collinear expression of
Hox genes during development [14,26,27].
On the other hand, the tight packing structure of Hox genes
makes it difficult to alter the expression profiles of these genes and
to explain how each gene is influenced differently by a common
regulator. Therefore, distinguishing the expression patterns of
each Hox gene may require an enhancer insulator or boundary
element system similar to that proposed in Drosophila melanogaster
[2]. We have previously presented several lines of evidence that
such regulatory elements exist in the mammalian Hox complex
[9,18,28]. In the present study, we determined the functional
sequence of one boundary element of the mouse HoxD complex
and analyzed the mechanisms of its function.
Tissue specificity of enhancer–blocker function
The expression profiles of Evx2 and Hoxd13 genes have many
aspects in common, such as initiation timing and expression in the
future digit domain. However, Evx2 is strongly expressed in the
CNS, while Hoxd13 is not. Interestingly, both of the enhancers that
drive these genes in digits and brain are located and oriented
similarly in relation to the HoxD complex, i.e., about 250 kb
beyond Evx2 and Hoxd13 [17].
Several lines of evidence indicate that these differences derive
from the ability of enhancers to differentially associate with
different promoters. In the present study, we demonstrated that
the functional region underlying insulator activity in our system
comprises two units—a 2.5 kb fragment having constitutive
blocker activity and a functional sequence regulating tissue
specificity of the insulator activity. The detailed mechanistic basis
of the interaction between these two functional sequences remains
to be clarified. However, our series of targeted transgene experi-
Figure 5. Premature expression of Hoxd13 observed in XB-targeted
transgenic mice. (A) Hoxd13 expression in 7 dpc embryos was
specifically upregulated. Sample RNA levels were normalized according
to b-actin mRNA levels. W1–W3, samples from three litters arising from
wild-type mice; B1–B6, samples from six litters arising from internally
bred BB-transgenic mice; X1–X8, samples from eight litters arising from
internally bred XB-transgenic mice. (B) Hypothetical scheme for
premature expression of these genes in XB-transgenic mice. The region
downstream of Evx2 recruits repression over the Hox complex before
the 7-dpc embryonic stage in preparation for Hox expression in wild-
type and BB-targeted transgenic mice. The XB fragment disrupts
repression, preventing the repressor region downstream of Evx2 from
recruiting repression into the HoxD complex.
doi:10.1371/journal.pone.0000175.g005
Figure 6. Position-effect blocker activity of the XB fragment. (A)
Constructs introduced into the NIH3T3 cell line. Construct I (top)
contains a CAGGS promoter-driven fluorescent protein (Venus) and
a neomycin-resistance gene, enabling G418 selection of stable
transformant colonies of transfected NIH3T3 cells. Construct II (bottom)
is organized similarly, except it contains XB blocker fragments
bordering both sides of the Venus expression marker gene. (B)
Experimental scheme illustrating the transfection scenario. Stable
transformants of both constructs were selected using G418. Colonies
were maintained in culture for one year. We selected samples from each
colony after 1, 6, and 12 months for FACS analyses. (C) Fluorescence
assessment of 12 colonies harboring either Construct I or Construct II.
Fewer fluorescent cells were observed in colonies lacking the XB
fragment, while numerous fluorescent cells were observed in colonies
harboring the XB fragment, indicating that the XB construct (Construct
II) maintained Venus expression.
doi:10.1371/journal.pone.0000175.g006
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blocker (insulator) sequence function in digits and genitalia, thus
supporting our hypothesis that chromatin makeup affects tissue-
specific dynamics. In addition, methylation assays revealed that, in
limbs or body parts in which the insulator sequence does not
function, a hypomethylated form of the insulator prevails. The
regulator sequence may play a crucial role in regulating the
methylation of the insulator sequence, and hence in regulating
insulator function.
Comparison with b-globin system
The HS4 fragment from the chicken b-globin locus is a well-known
insulator sequence identified in vertebrates. Extensive examination
of HS4 showed that this sequence has two separable activities—
insulator activity and position-effect protection activity—each of
which arises from two short and distinct DNA elements [29].
Unlike in the case of chick HS4, we were unable to dissect the
functional insulator fragment apart from the 2.5 kb fragment, and
thus were unable to isolate from the Evx2-Hoxd13 intergenic
fragment the short sequence responsible for insulator activity or
position-effect protection activity. In the chick b-globin locus,
a CTCF-binding sequence is required and sufficient to block
enhancer-promoter interaction [19], and another sequence is
required for position-effect protection [29]. The H19/Igf2
imprinting region also has CTCF-binding sites that function as
insulator sequences in the imprinting system [21,22]. In our
system, however, we were unable to identify a CTCF-binding
sequence by in silico screening or by chromatin immunoprecipi-
tation assays (ChIP) using an anti-CTCF antibody (Kondo,
unpublished data). Together, these findings suggest that the
mechanisms underlying boundary activity in Evx2-HoxD are
different from those underlying boundary activity in the b-globin
and H19 systems [21,22].
Functioning mode of the chromatin boundary
element
We observed transgene expression in the CNS, limbs, and genitalia
of transgenic mice harboring constructs in which promoters were
inserted into the genomic region between Evx2 and CNS and/or
limb enhancers (GCR) [14,17,28]. Genes located beyond Hoxd13,
however, showed no expression in CNS. Thus, boundary elements
probably define the range of a chromosomal domain in which
transcription factors can search for a promoter.
Enhancer titration or competition can be a possible mechanism
of the Evx2-Hoxd13 insulator [18,28]. It is generally believed that
some spatially close promoters compete for enhancers [30].
Indeed, the XB fragment may contain the Evx2 promoter.
However, the XB fragment—the enhancer blocker (insulator)—
did not show promoter activity when we randomly inserted it into
the genome as a transgene (Kondo, unpublished data). Addition-
ally, titration or competition appears to occur specifically against
the neural enhancer not the limb enhancer, even though Evx2
promoter activity is prominent in both of these tissues. Specificity
depended on the presence of an additional sequence (BNs frag-
ment) next to the XB fragment, suggesting that even if the XB
fragment has promoter activity when it is inserted near Evx2,
promoter activity is not a decisive factor dictating whether the
sequence will function as a blocker.
In addition, enhancer titration cannot explain the position-effect
protection activity we observed in our study system. Although
these findings may not directly exclude the possibility, we believe
that the enhancer insulation occurring in the Evx2-Hoxd13 system
is not driven entirely by promoter titration.
Differential expression of Evx2 and Hoxd13 in the CNS may also
be due to uni-directional repression activity. In this scheme, the
XB fragment recruits repression from only one side (side adjacent
to the BamHI restriction site) of the flanking sequences. The BNs
fragment, on the other hand, disturbs this repression activity in the
limbs and genital bud, and as a result, posterior Hoxd genes are
repressed in the CNS. The unidirectional repression activity
scenario, however, cannot explain why Evx2 and Hoxd13 were
prematurely expressed in XB-targeted transgenic mice. Addition-
ally, this scenario cannot account for our transfection assay results
showing that the genes adjacent to the BamHI side of the XB
fragment maintained active transcription and the XB fragment
showed protection activity against repression from the genomic
environment where the transgenes were inserted. These phenom-
ena contradict the unidirectional repression hypothesis.
Boundary elements are candidate sequences that divide
chromosomal DNA into units, regulating promoter-enhancer
interactions and the extent of chromatin remodeling [8,31].
Our findings prompt a revision of this traditional definition of
chromatin boundary sequences, one including protection activity
against negative chromatin spreading in addition to enhancer
blocker activity. We showed that the sequence identified in this
series of experiments is a proper boundary sequence, since it had
position-effect protection activity as well as insulator activity.
According to Corces and colleagues, boundary sequences are
important for the three-dimensional assembly of chromosomal
DNA [31]; these sequences, therefore, appear to represent consti-
tutive activity that forms the structural basis of genomic DNA.
Although we could not detect the CTCF association on this
boundary region, seeking associating factors on this boundary
region is one of the important aspects to reveal the mechanisms of
boundary function. Previous studies on Drosophila boundary
elements raised several candidates for associating factors, such as
BEAF-32 [32], Su(Hw), Mod(mdg4) [33], Pleiohomeiotic (Pho)o r
Trithorax-like (Trl=GAGA factor) [34]. Unfortunately, mammalian
homologues of most of these factors remain elusive. However,
potential association of Pho and Trl suggests the involvement of
Polycomb group genes (PcG) and trithorax group genes (trxG) in the
boundary function in Drosophila melanogaster. In vertebrate systems,
PcG or trxG factors may also be involved in the boundary function
through histone modifications.
In the present study, we demonstrated that the Evx2-HoxD
boundary element operates in tissue- and time-specific modes.
This boundary element is composed of two functional fragments—
a constitutive boundary element and a boundary regulator
fragment—the latter of which gives tissue specificity to the
constitutive boundary element. The constitutive boundary element
can protect promoters from the repressive influence of chromo-
somal environments when it is inserted along with promoters. This
finding also indicates that constitutive boundary elements can be
useful tools for stably expressing exogenous promoters in
eukaryotic cells.
MATERIALS AND METHODS
Targeted transgene
A construct containing the Hoxd9/lacZ indicator transgene, which
was inserted into a HindIII site just downstream of the Evx2 gene,
and a test fragment (from the 59-flanking region of the transgene)
was introduced into R1 ES cells by electroporation. ES cells were
selected by using neomycin resistance, and homologous recombi-
nants were isolated by genomic Southern hybridization as previously
described [14]. Chimeras were created with these homologous
recombinant ES cells to establish targeted transgenic animals.
Enhancer Association to HoxD
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NIH3T3 cells were cultured in Dulbecco’s Modified Eagle’s
Medium supplemented with 10% fetal bovine serum. Constructs
containing either a Venus expression marker gene or a Venus
marker flanked by candidate boundary sequences (XB fragment)
were introduced into NIH3T3 cells by electroporation. Twelve
colonies from each pool of transformants containing the two
constructs were randomly isolated and used for further testing. We
continued to culture these transformants, assessing their fluores-
cence 1, 6, and 12 months after starting the culture by FACS.
Bisulfite DNA methylation assay
Genomic DNA samples were isolated from forelimbs and
hindbrain regions of 11 dpc embryos. After digestion of DNA by
XhoI and purification steps, digested DNA samples were subjected
to bisulfite modification [23]. Modified DNA was amplified with
PCR, then subcloned into pBSK for sequencing. We sequenced 10
colonies from each pool. The PCR primers we used were as
follows:
Pair 1,
59-GGGAGGATATAGGAAGAGTTG-39,
59-CTCTATACCCCCAATCAACAC-39;
Pair 2,
59-GTGTTGATTGGGGGTATAGAG-39,
59-ACCTCACCTCCCCTTACATTC-39;
Pair 3,
59-GTGTTAGGGGGTAAATTTTTG-39,
59-CAAAAATTCTCTTCTAATCCC-39.
Gene expression study
b-galactosidase staining and in situ hybridization were performed
according to established protocols. The Hoxd13 probe was
described by Dolle ´ et al. [35]. The Evx2 probe was derived from
an XbaI-BamHI genomic fragment of the Evx2 gene corresponding
to the 39 UTR of Evx2 gene.
We also assessed Hoxd13 gene expression by real-time PCR
using a Corbett RG-3000 with Invitrogen Platinum SYBRGreen
PCR kit. We isolated mRNA from 7 dpc embryos from three
different pregnant wild-type mice (wild-type matings), six different
pregnant BB/2 mice (BB-targeted transgenic heterozygotic
matings), and eight different pregnant XB/2 mice (XB-target
transgenic matings). Each cDNA sample was derived from mRNA
pooled from each litter, which was composed of several embryos
(e.g., three cDNA samples from wild-type mice; six cDNA samples
from BB/2 mice; eight cDNA samples from XB mice).
To control for the amount of cDNA, we carried out PCR with
b-actin.
We used the following primers:
b-actin,
59- CATGTTTGAGACCTTCAACAC-39,
59- GTGATGACCTGGCCGTCAGG-39;
Hoxd13,
59- GGTTTCCCGGTGGAGAAGTAC-39,
59- TGGACACCATGTCGATGTAGC-39.
We performed PCR in triplicate for each pool of cDNA and
calculated the amounts of products using a standard curve made
by sequential dilutions of isolated cDNAs for b-actin and Hoxd13.
SUPPORTING INFORMATION
Figure S1 LacZ expression of targeted transgenic mice de-
scribed previously [1]. (A) Positions of targeted transgene. The
Hoxd9/lacZ marker transgene was inserted half-way between
Evx2 and Hoxd13 by using the ES cell technique to produce relO
mice. The Hoxd9/lacZ transgene is immediately downstream of
Evx2 in relI mice. The resulting ES cells were injected into
blastocysts to establish transgenic mice. (B) In relI embryos, the
lacZ-staining pattern in the isthmus resembles the expression
pattern of Evx2. (C) LacZ-staining pattern indicates that relO mice
do not express the transgene in brain, which is consistent with our
Hoxd13 in situ hybridization results.
Found at: doi:10.1371/journal.pone.0000175.s001 (0.02 MB
PDF)
Figure S2 Sequence of boundary fragment. (A) Physical map of
region including boundary sequence. The boundary fragment is
indicated in red line. The numbers in parenthesis indicate the
distance from XhoI site in the first exon of Evx2. (B) Sequence of
XB-boundary fragment. The initiation codon of Evx2 gene is
indicated with blue font.
Found at: doi:10.1371/journal.pone.0000175.s002 (0.02 MB
PDF)
Figure S3 Sequence of boundary regulator fragment. (A)
Physical map of region including boundary regulator sequence.
The boundary regulatory fragment is indicated in dark blue line.
The numbers in parenthesis indicate the distance from XhoI site
in the first exon of Evx2. (B) Sequence of BNs-boundary regulator
fragment.
Found at: doi:10.1371/journal.pone.0000175.s003 (0.02 MB
PDF)
Text S1 Supporting Information legends and references.
Found at: doi:10.1371/journal.pone.0000175.s004 (0.03 MB
DOC)
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